Moderna’s (MRNA) marketing application for its flu vaccine, mRNA-1010, will be reviewed by the FDA's independent experts next month, according to a federal notice posted on Thursday. The meeting of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results